Cargando…
E. coli-Produced Monophosphoryl Lipid a Significantly Enhances Protective Immunity of Pandemic H1N1 Vaccine
Emerging influenza viruses pose an extreme global risk to human health, resulting in an urgent need for effective vaccination against influenza infection. Adjuvants are vital components that can improve vaccine efficacy, yet only a few adjuvants have been licensed in human vaccines. Here, we investi...
Autores principales: | Nguyen, Quyen Thi, Kim, Eunjin, Yang, Jihyun, Lee, Chankyu, Ha, Da Hui, Lee, Choon Geun, Lee, Ye Ram, Poo, Haryoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350214/ https://www.ncbi.nlm.nih.gov/pubmed/32560094 http://dx.doi.org/10.3390/vaccines8020306 |
Ejemplares similares
-
Immuno-Stimulatory Activity of Escherichia coli Mutants Producing Kdo(2)-Monophosphoryl-Lipid A or Kdo(2)-Pentaacyl-Monophosphoryl-Lipid A
por: Wang, Biwen, et al.
Publicado: (2015) -
A Murine CD8(+) T Cell Epitope Identified in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
por: Yang, Jihyun, et al.
Publicado: (2021) -
Poly-γ-Glutamic Acid Complexed With Alum Induces Cross-Protective Immunity of Pandemic H1N1 Vaccine
por: Nguyen, Quyen Thi, et al.
Publicado: (2019) -
Construction of Monophosphoryl Lipid A Producing Escherichia coli Mutants and Comparison of Immuno-Stimulatory Activities of Their Lipopolysaccharides
por: Han, Yaning, et al.
Publicado: (2013) -
Poly-γ-glutamic acid/chitosan nanogel greatly enhances the efficacy and heterosubtypic cross-reactivity of H1N1 pandemic influenza vaccine
por: Yang, Jihyun, et al.
Publicado: (2017)